Search the Newsreel

ARS Pharmaceuticals (SPRY) Stock Faces Margin Squeeze As Losses Deepen

Walleye Capital LLC Invests $4.84 Million in Xeris Biopharma Holdings, Inc. $XERS

Walleye Capital LLC has invested $4.84 million in Xeris Biopharma Holdings, Inc. by acquiring 611,296 shares in the second quarter, representing 0.35% of the company. Institutional investors collectively own 42.75% of Xeris. Despite reporting higher-than-expected revenue of $92.1 million, the company posted an adjusted …

Walleye Capital LLC Buys New Position in Xenon Pharmaceuticals Inc. $XENE

Walleye Capital LLC has acquired a new position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE), purchasing 76,955 shares valued at approximately $4.65 million. This move is amidst positive analyst sentiment with a "Buy" rating and a $77.13 average price target, despite recent insider stock sales totaling …

Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress

Amylyx Pharmaceuticals (AMLX) stock has seen a 170.4% return over the past year, but its valuation metrics suggest it is trading at a premium. The progress of the avexitide trial, including its completed pivotal trial and potential commercial launch, supports future cash flow expectations, …

Redcare Pharmacy Aktie • A2AR94 • NL0012044747

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands

Madrigal Pharmaceuticals' drug Rezdiffra achieved a $1.3 billion trailing-12-month revenue run rate in Q2 2026, with revenue up 71% year-over-year and over 49,000 active patients. The company is expanding its MASH pipeline to 10 assets, primarily for combination with Rezdiffra, targeting weight loss, liver-fat …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Royal Bank of Canada Boosts Holdings in Triumph Financial, Inc. $TFIN

Fire Capital Management LLC Boosts Stock Position in Alphabet Inc. $GOOG

Fire Capital Management LLC significantly increased its stake in Alphabet Inc. ($GOOG) by 137.3% in the second quarter, bringing its total holdings to 8,648 shares valued at $3.06 million. Despite some negative sentiment regarding AI investment costs and competitive pressures, institutional investors collectively own …

Why Alphatec Holdings (ATEC) Is Up 5.9% After Reaffirming 2026 Outlook And Narrowing Q2 Losses

Alphatec Holdings (ATEC) saw its stock rise 5.9% after reporting narrowed Q2 net losses and reaffirming its 2026 revenue guidance of approximately US$882 million. The company also filed a shelf registration for 800,000 common shares. This performance highlights Alphatec's cost discipline and continued investment …

Milestone’s FDA Win Now Faces A Tougher Test: Sales

Milestone Pharmaceuticals (NASDAQ: MIST) recently gained FDA approval for its lead product, CARDAMYST™ (etripamil) nasal spray, for PSVT. However, the company now faces the challenge of commercializing the product, with early sales and market sentiment being mixed. The success of CARDAMYST depends heavily on …

How Securities Lawsuits Over Trial Disclosures Will Impact Regeneron Pharmaceuticals’ (REGN) Pipeline-Driven Investment Story

Regeneron Pharmaceuticals is facing securities class action lawsuits concerning alleged misleading statements about its Phase III Fianlimab-Libtayo trial. These lawsuits, focusing on disclosure practices regarding trial delays and failure, could influence investor perception of Regeneron's pipeline-driven strategy, especially as the company advances new programs …

Can Enphase Energy (ENPH) Hold Its Premium After Manufacturing Push?

Enphase Energy's stock has declined significantly over five years but now trades near its intrinsic value and market multiples. The company's recent expansion into U.S. manufacturing for power electronics and AI data center infrastructure supports long-term cash flow expectations. While valuation models suggest the …

Empowered Funds LLC Buys 119,202 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR

Empowered Funds LLC significantly increased its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) by 661.6% in the first quarter, adding 119,202 shares to reach a total of 137,220 shares valued at $8.6 million. This move is part of a broader trend of institutional investment, with …

Diversified Trust Co. Trims Position in Parker-Hannifin Corporation $PH

Diversified Trust Co. significantly reduced its stake in Parker-Hannifin Corporation (NYSE:PH) by 63.4% in the second quarter, selling 3,465 shares and retaining 2,001 shares valued at $1.96 million. Despite this trimming by one institutional investor, other hedge funds increased their positions, and institutional investors …

IONS Stock Jumps 4% After-Hours — Goldman Sachs Lifts Price Target On Tryngolza Approval

Bank of America Corp DE Boosts Stake in Kiniksa Pharmaceuticals International, plc $KNSA

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from Analysts

NRx Pharmaceuticals (NASDAQ:NRXP) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $34.50. Despite this, the company recently missed its quarterly earnings and revenue estimates. Hedge funds and institutional investors hold 4.27% of the stock.

Teleconferência de Resultados do 2º Trimestre de 2026 da Alpha Cognition (ACOG): Vendas do ZUNVEYL Subem 71%

Alpha Cognition (ACOG) reportou um crescimento de 71% nas vendas líquidas do ZUNVEYL no 2º trimestre de 2026, atingindo US$ 6 milhões, impulsionado pela demanda de 8.294 frascos. A empresa reduziu sua projeção de despesas operacionais para o ano fiscal de 2026 para US$ …

Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen has upgraded Connect Biopharma (NASDAQ:CNTB) from a "sell" to a "hold" rating, though the broader analyst consensus remains a "Moderate Buy" with an average price target of $7.43. The company recently reported a quarterly loss of $0.27 per share, outperforming expectations, …

Vertex (VRTX) Stock Looks Above Fair Value On Earnings Yet About Right Overall

Vertex Pharmaceuticals (VRTX) has seen strong multi-year performance, with a 158.2% return over the past five years, but its current valuation suggests it's neither a clear bargain nor obviously overvalued. The stock trades at 29.1x earnings, slightly above Simply Wall St's fair P/E estimate …

Cathie Wood’s ARK Invest Loads Up On CRWV, GOOGL Stocks Before Mega Tech Earnings Day

Key facts: GOOG investment gains; Gemini 950M users; Waymo expands

Alphabet (GOOG) reported significant Q2 investment gains, making up about 10% of S&P 500 earnings, primarily from revaluation of equity stakes like SpaceX and Anthropic. Its AI model, Gemini, reached 950 million monthly users and is being integrated across Google products. Additionally, Waymo received …

Nouveau Monde Graphite (NYSE:NMG) Upgraded to Hold at Wall Street Zen

Wall Street Zen has upgraded Nouveau Monde Graphite (NYSE:NMG) from a "sell" to a "hold" rating. Despite this, MarketBeat indicates a consensus "Moderate Buy" rating with an average price target of $4.67 for the stock. NMG shares opened at $1.47, near their 52-week low, …

5-Day Rally Sends Phillips 66 Stock Up 15%

ARWR Stock Clocks Best Day In Nearly 8 Months As Analyst Lifts Price Target On Plozasiran Data

Alpha and Omega Semiconductor (AOSL) Stock May Be Undervalued Despite Q4 Loss Preview

Wall Street Zen Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy

Wall Street Zen has upgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "buy" to a "strong-buy" rating. This upgrade follows Regeneron's strong quarterly earnings, where it surpassed analyst expectations for both EPS and revenue. Despite positive news regarding pipeline expansion and collaborations, the company faces risks …

Spheria Emerging Companies (ASX:SEC) Brings Small-Cap Exposure Into the August Dividend Calendar

NewAmsterdam Pharma (NAMS) Earnings Losses Raise The Question Of Whether The Stock Is A Bargain

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen has upgraded Inovio Pharmaceuticals (NASDAQ:INO) from a "Sell" to a "Hold" rating, though overall analyst opinions remain mixed, with MarketBeat reporting a "Moderate Buy" consensus. The company recently exceeded earnings estimates, reporting a quarterly EPS of negative $0.07 against an expected …

Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121

Eledon Pharmaceuticals (NASDAQ:ELDN) Upgraded at Wall Street Zen

Wall Street Zen upgraded Eledon Pharmaceuticals (NASDAQ:ELDN) from "strong sell" to "sell," though the broader analyst consensus remains "Hold" with a $9.67 target price. The company reported a quarterly loss of $0.27 per share, missing estimates, and its shares opened at $3.54. Institutional investors …

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen has upgraded Oramed Pharmaceuticals (NASDAQ:ORMP) from a "hold" to a "buy" rating, though MarketBeat's overall analyst rating for the company remains "Hold." Oramed Pharmaceuticals opened at $4.48, with a market capitalization of $186.35 million. The company recently reported a quarterly loss …

Roundhill GOOGL WeeklyPay ETF To Go Ex-Dividend On August 17th, 2026 With 0.39199 USD Dividend Per Share

The Roundhill GOOGL WeeklyPay ETF is set to go ex-dividend on August 17th, 2026. Shareholders will receive a dividend of 0.39199 USD per share.

NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen